Prathyusha Duraibabu
2021
Compensation breakdown
Non-Equity Incentive Plan | $127,439 |
---|---|
Option Awards | $319,108 |
Salary | $362,586 |
Stock Awards | $242,063 |
Other | $5,554 |
Total | $1,056,750 |
Duraibabu received $362.6K in salary, accounting for 34% of the total pay in 2021.
Duraibabu also received $127.4K in non-equity incentive plan, $319.1K in option awards, $242.1K in stock awards and $5.6K in other compensation.
Rankings
In 2021, Prathyusha Duraibabu's compensation ranked 8,616th out of 12,415 executives tracked by ExecPay. In other words, Duraibabu earned more than 30.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 8,616 | 31st |
Manufacturing | 3,821 | 31st |
Chemicals And Allied Products | 1,691 | 29th |
Drugs | 1,505 | 28th |
Biological Products, Except Diagnostic Substances | 328 | 27th |
Pay ratio
Prathyusha Duraibabu's Pay | $1,056,750 |
---|---|
Median Employee's Pay | $170,218 |
Pay Ratio | 6to 1 |
In 2021, the annual total compensation of Prathyusha Duraibabu was $1,056,750.
The annual total compensation of the median employee at Sangamo Biosciences was $170,218.
The ratio of Prathyusha Duraibabu's pay to the pay of median employee was therefore 6 to one.
Duraibabu's colleagues
We found five more compensation records of executives who worked with Prathyusha Duraibabu at Sangamo Biosciences in 2021.
2021
Alexander Macrae
Sangamo Biosciences
Chief Executive Officer
2021
Robert Schott
Sangamo Biosciences
Senior Vice President, Head of Development
2021
R Ramelmeier
Sangamo Biosciences
Executive Vice President, Technical Operations
2021
D McClung
Sangamo Biosciences
Chief Operating Officer
2021
Sung Lee
Sangamo Biosciences